Halozyme Therapeutics
- Biological Products, Except Diagnostic Substances
- San Diego, California
Compensation history
Top executives at Halozyme Therapeutics received an average of $2M per person in annual compensation from 2005 to 2021.
Average pay of disclosed executives at Halozyme Therapeutics
By year
- 2021
HT$7MHelen I. TorleyPresident and Chief Executive OfficerMM$3MMasaru MatsudaSenior Vice President, General Counsel, Chief Compliance Officer and Corporate SecretaryML$2MMichael J. LaBarreSenior Vice President, Chief Technical OfficerES$2MElaine D. SunSenior Vice President Chief Financial Officer- 2020
HT$7MHelen I. TorleyPresident and Chief Executive OfficerES$3MElaine D. SunSenior Vice President Chief Financial OfficerML$2MMichael J. LaBarreSenior Vice President, Chief Technical OfficerMM$2MMasaru MatsudaSenior Vice President, General Counsel, Chief Compliance Officer and Corporate SecretaryLS$171KLaurie D. StelzerFormer Senior Vice President, Chief Financial Officer- 2019
HT$6MHelen I. TorleyPresident and Chief Executive OfficerAA$3MAlison ArmourFormer Senior Vice President, Head of Research & DevelopmentLS$2MLaurie D. StelzerFormer Senior Vice President, Chief Financial OfficerBH$2MBenjamin J. HickeyFormer Senior Vice President, Chief Commercial OfficerHL$2MHarry J. LeonhardtFormer Senior Vice President, General Counsel
Executives
We found 22 executives who work or worked at Halozyme Therapeutics.
Helen Torley
Halozyme Therapeutics
Chief Executive Officer
Elaine Sun
Halozyme Therapeutics
Chief Financial Officer
Masaru Matsuda
Halozyme Therapeutics
General Counsel
Michael LaBarre
Halozyme Therapeutics
Senior Vice President, Chief Technical Officer
Laurie Stelzer
Halozyme Therapeutics
Chief Financial Officer
Harry Leonhardt
Halozyme Therapeutics
General Counsel
Alison Armour
Halozyme Therapeutics
Former Senior Vice President, Head of Research & Development
Benjamin Hickey
Halozyme Therapeutics
Former Senior Vice President, Chief Commercial Officer
News
Halozyme Therapeutics CEO Helen Torley's 2021 pay rises 14% to $7.5M
March 25, 2022
Halozyme Therapeutics CEO Helen Torley's 2020 pay rises 11% to $6.5M
March 26, 2021
Halozyme Therapeutics CEO Helen Torley's 2019 pay rises 1% to $5.9M
March 20, 2020
Halozyme Therapeutics CEO Helen Torley's 2018 pay rises 12% to $5.8M
March 22, 2019
About Halozyme Therapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryBiological Products, Except Diagnostic Substances
- Address11388 Sorrento Valley Road, San Diego, California 92121-1345
- Phone(858) 794-8889
- Fiscal year endDecember 31
- Former names
- HALOZYME THERAPEUTICS INCUntil July 2, 2019
- GLOBAL YACHT SERVICES INCUntil March 11, 2004
Source: SEC filings on March 25, 2022, March 26, 2021, March 20, 2020, March 22, 2019, March 22, 2018, March 24, 2017, March 23, 2016, April 3, 2015, March 29, 2012, March 24, 2011, April 1, 2010, April 2, 2009, and April 3, 2008.